Status:
UNKNOWN
Chronic Heart Failure Analysis and Registry in the Tohoku District 2 (CHART-2 Study)
Lead Sponsor:
Hiroaki Shimokawa, MD, PhD
Conditions:
Heart Failure
Coronary Disease
Eligibility:
All Genders
20+ years
Brief Summary
Chronic Heart Failure Analysis and Registry in the Tohoku District 2 (CHART-2 Study) is a large, prospective, hospital-based cohort study to investigate the following: * Characteristics of patients w...
Detailed Description
The CHART-2 Study is a multicenter prospective observational cohort study identifying the characteristics, mortality and prognostic risks of patients with overt HF and patients without HF but who are ...
Eligibility Criteria
Inclusion
- Structural heart disease but without signs or symptoms of heart failure.
- Structural heart disease with prior or current symptoms of heart failure.
- Refractory heart failure requiring specialized interventions.
- Patients with prior cardiovascular surgery or percutaneous coronary intervention and those who need such interventions.
Exclusion
- Patients with age\<20 years old.
- Patients who refused to participate.
Key Trial Info
Start Date :
October 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2019
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT00418041
Start Date
October 1 2006
End Date
December 1 2019
Last Update
May 12 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
Sendai, Japan, 980-8574